The effect of metoclopramide and haloperidol on tardive dyskinesia [proceedings].
作者信息
Bateman D N, Dutta D K, McClelland H A, Rawlins M D
出版信息
Br J Pharmacol. 1979 Jul;66(3):475P-476P.
Abstract
摘要
相似文献
1
The effect of metoclopramide and haloperidol on tardive dyskinesia [proceedings].甲氧氯普胺和氟哌啶醇对迟发性运动障碍的影响[会议记录]
Br J Pharmacol. 1979 Jul;66(3):475P-476P.
2
Molindone and haloperidol in tardive dyskinesia.
J Clin Psychiatry. 1985 Aug;46(8 Pt 2):4-7.
3
The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders.甲氧氯普胺所致迟发性运动障碍和急性锥体外系运动障碍的患病率。
Arch Intern Med. 1993 Jun 28;153(12):1469-75.
4
A ketamine-induced rat model of tardive dyskinesia.一种氯胺酮诱导的迟发性运动障碍大鼠模型。
Prog Neurobiol. 1992 Jun;38(6):571-600. doi: 10.1016/0301-0082(92)90042-d.
5
Metoclopramide, an increasingly recognized cause of tardive dyskinesia.甲氧氯普胺是迟发性运动障碍一个越来越被认可的病因。
J Clin Pharmacol. 2008 Mar;48(3):379-84. doi: 10.1177/0091270007312258. Epub 2008 Jan 25.
6
Tardive dyskinesia presenting as gastrointestinal disorder.迟发性运动障碍表现为胃肠道疾病。
J Clin Psychiatry. 1990 Jun;51(6):253-4.
7
Effects of intravenous metoclopramide in 81 patients with tardive dyskinesia.静脉注射甲氧氯普胺对81例迟发性运动障碍患者的影响。
J Clin Psychopharmacol. 1982 Dec;2(6):376-9.
8
Exacerbation of tardive dyskinesia by Joseph disease.约瑟夫病导致迟发性运动障碍加重。
J Clin Psychiatry. 1986 Jun;47(6):315-6.
9
Tardive dyskinesia: effect of age, sex, and criterion level of symptomatology on prevalence estimates [proceedings].迟发性运动障碍：年龄、性别及症状学标准水平对患病率估计的影响[会议论文集]
Psychopharmacol Bull. 1979 Apr;15(2):69-71.
10
Tardive dyskinesia: pathophysiology and animal models.迟发性运动障碍：病理生理学与动物模型
J Clin Psychiatry. 2000;61 Suppl 4:5-9.
引用本文的文献
1
Antipsychotic reduction and/or cessation and antipsychotics as specific treatments for tardive dyskinesia.抗精神病药物的减量和/或停用以及抗精神病药物作为迟发性运动障碍的特定治疗方法。
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD000459. doi: 10.1002/14651858.CD000459.pub3.
2
Non-antipsychotic catecholaminergic drugs for antipsychotic-induced tardive dyskinesia.用于抗精神病药物所致迟发性运动障碍的非抗精神病类儿茶酚胺能药物。
Cochrane Database Syst Rev. 2018 Jan 18;1(1):CD000458. doi: 10.1002/14651858.CD000458.pub3.
3
Antipsychotic medication for elderly people with schizophrenia.用于老年精神分裂症患者的抗精神病药物。
Cochrane Database Syst Rev. 2006 Jan 25;2006(1):CD005580. doi: 10.1002/14651858.CD005580.
本文引用的文献
1
[Clinical and electroencephalographic effects of methoclopramide in psychiatry].甲氧氯普胺在精神病学中的临床及脑电图效应
Therapie. 1965 Jul-Aug;20(4):975-95.
2
Idiopathic Parkinsonism treated with an extracerebral decarboxylase inhibitor in combination with levodopa.用脑外脱羧酶抑制剂与左旋多巴联合治疗特发性帕金森病。
Br Med J. 1971 Sep 25;3(5777):729-32. doi: 10.1136/bmj.3.5777.729.
3
Inhibition by apomorphine of the metoclopramide-induced catalepsy and increase in striatal homovanillic acid content.阿扑吗啡对胃复安诱导的僵住症的抑制作用及纹状体高香草酸含量的增加。
Br J Pharmacol. 1975 Nov;55(3):381-5. doi: 10.1111/j.1476-5381.1975.tb06941.x.
4
Tardive dyskinesia associated with metoclopramide.与甲氧氯普胺相关的迟发性运动障碍。
Br Med J. 1978 Jan 14;1(6105):77-8. doi: 10.1136/bmj.1.6105.77.
5
Cardiovascular dopamine receptor stimulation antagonized by metoclopramide.甲氧氯普胺拮抗心血管多巴胺受体刺激。
J Pharm Pharmacol. 1975 Apr;27(4):276-8. doi: 10.1111/j.2042-7158.1975.tb10699.x.
6
The neuropharmacology of abnormal involuntary movement disorders (the dyskinesias).异常不自主运动障碍（运动障碍）的神经药理学
Mod Trends Neurol. 1975;6:141-66.
7
Extrapyramidal side-effects of metoclopramide.
Lancet. 1978 Dec 9;2(8102):1254-5. doi: 10.1016/s0140-6736(78)92126-8.
Zotero 插件